Protagenic Therapeutics, Inc. (PTIX)
0.4174
0.00 (0.00%)
USD |
OTCM |
Nov 19, 16:00
Protagenic Therapeutics Free Cash Flow : -1.681M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.681M |
| June 30, 2026 | -2.587M |
| March 31, 2026 | -3.394M |
| December 31, 2025 | -4.724M |
| September 30, 2025 | -5.034M |
| June 30, 2025 | -3.825M |
| March 31, 2025 | -3.625M |
| December 31, 2024 | -4.216M |
| September 30, 2024 | -4.635M |
| June 30, 2024 | -5.161M |
| March 31, 2024 | -5.141M |
| December 31, 2023 | -3.854M |
| September 30, 2023 | -2.798M |
| June 30, 2023 | -2.622M |
| March 31, 2023 | -1.937M |
| December 31, 2022 | -1.996M |
| September 30, 2022 | -2.218M |
| June 30, 2022 | -2.758M |
| March 31, 2022 | -2.622M |
| December 31, 2021 | -2.799M |
| September 30, 2021 | -2.714M |
| June 30, 2021 | -2.157M |
| March 31, 2021 | -1.592M |
| December 31, 2020 | -1.349M |
| September 30, 2020 | -1.177M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.7213M |
| March 31, 2020 | -0.6564M |
| December 31, 2019 | -0.488M |
| September 30, 2019 | -0.6464M |
| June 30, 2019 | -0.7442M |
| March 31, 2019 | -1.008M |
| December 31, 2018 | -1.071M |
| September 30, 2018 | -1.180M |
| June 30, 2018 | -1.380M |
| March 31, 2018 | -1.282M |
| December 31, 2017 | -1.380M |
| September 30, 2017 | -1.305M |
| June 30, 2017 | -1.242M |
| March 31, 2017 | -1.440M |
| December 31, 2016 | -1.140M |
| September 30, 2016 | -0.8935M |
| June 30, 2016 | -0.6904M |
| March 31, 2016 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2011 | -6.944M |
| June 30, 2011 | -10.03M |
| March 31, 2011 | -11.63M |
| December 31, 2010 | -11.29M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oncolytics Biotech, Inc. | -28.39M |
| Sangamo Therapeutics, Inc. | -90.46M |
| Sarepta Therapeutics, Inc. | 167.79M |
| Anixa Biosciences, Inc. | -7.376M |
| Vicapsys Life Sciences, Inc. | -0.1292M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.4889M |
| Free Cash Flow Per Share (Quarterly) | -0.2701 |
| Free Cash Flow to Equity (Quarterly) | -0.4889M |
| Free Cash Flow to Firm (Quarterly) | -0.4889M |
| Free Cash Flow Yield | -222.4% |